Keywords: sanofi-synthelabo, 2nd, qtr, sales, rise, french, drugmaker
Sanofi-Synthelabo 2nd qtr sales rise 11%
Article | 26 July 2000
French drugmaker Sanofi-Synthelabo says sales in the second quarter of2000 rose 11% to 1.50 billion euros ($1.39 billion) and 10.1% to 2.87 billion euros for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
